The percentage of SERT, 5HT2A, TPH1, ERK1/2, pERK1/2 positive areas in the control, degenerative mitral valve disease (DMVD) and degenerative mitral valve disease with pulmonary hypertension (DMVD+PH) groups. This evidence concerns the gene HTR2A and pulmonary arterial hypertension.